MILWAUKEE–(BUSINESS WIRE)–Sensient Technologies Corporation (NYSE: SXT) reported consolidated revenue of $369.0 million in this year’s first quarter compared to $355.5 million in last year’s first quarter. Reported operating income in the first quarter of 2023 was $50.8 million compared to $52.8 million in the first quarter of 2022. Reported diluted earnings per share was 80 cents in the first quarter of 2023 compared to 88 cents in the first quarter of 2022. Foreign currency translation decreased revenue by approximately 1% and earnings per share by approximately 2% in the current quarter.
|
BUSINESS REVIEW |
||||
|
Reported |
||||
| Revenue |
Quarter |
|||
| Flavors & Extracts |
-2.1% |
|||
| Color |
8.6% |
|||
| Asia Pacific |
9.9% |
|||
| Total Revenue |
3.8% |
|||
|
|
||||
|
|
||||
|
Local Currency(1) |
||||
| Revenue |
Quarter |
|||
| Flavors & Extracts |
-1.3% |
|||
| Color |
10.0% |
|||
| Asia Pacific |
14.6% |
|||
| Total Revenue |
5.2% |
|||
| (1) Local currency percentage changes are described in more detail in the “Reconciliation of Non-GAAP Amounts” at the end of this release. | ||||
The Flavors & Extracts Group reported first quarter revenue of $178.9 million compared to $182.7 million in last year’s first quarter, a decrease of 2.1%. Local currency revenue decreased 1.3% in the quarter. The Group’s revenue was negatively impacted by lower volumes, primarily due to customer destocking in certain product lines, partially offset by favorable pricing. Segment operating income was $22.2 million in the current quarter compared to $27.6 million reported in the comparable period last year, a decrease of 19.6%. Local currency operating income decreased 19.5% in the quarter. The lower operating income was primarily due to the lower volumes and higher input costs, partially offset by favorable pricing. Foreign currency translation decreased segment revenue by approximately 1% and was not material to segment operating income in the quarter.
The Color Group reported revenue of $161.2 million in the quarter compared to $148.4 million in last year’s first quarter, an increase of 8.6%. Local currency revenue increased 10.0% in the quarter. The Group benefited from higher pricing and higher volumes in the food and pharmaceutical product line, offset by lower volumes in the personal care product line, primarily due to customer destocking. Segment operating income was $31.9 million in the quarter compared to $30.7 million in last year’s comparable period, an increase of 4.0%. Local currency operating income increased 6.3% compared to the prior year’s first quarter. The higher operating income is primarily a result of the favorable pricing, partially offset by higher input costs. Foreign currency translation decreased segment revenue by approximately 1% and segment operating income by approximately 2% in the quarter.
The Asia Pacific Group reported revenue of $40.1 million in the quarter compared to $36.5 million in last year’s first quarter, an increase of 9.9%. Local currency revenue increased 14.6% in the quarter, primarily as a result of higher volumes and higher pricing. Segment operating income was $9.2 million in the quarter compared to $8.2 million in last year’s first quarter, an increase of 12.6%. Local currency operating income increased 18.0% in the quarter, primarily as a result of the higher volumes and pricing, partially offset by higher input costs. Foreign currency translation decreased segment revenue and operating income by approximately 5% in the quarter.
Corporate & Other reported an operating loss of $12.5 million in the current quarter compared to $13.7 million in last year’s first quarter, a decrease of 8.7%, primarily due to lower performance-based compensation.
2023 OUTLOOK
Sensient is reconfirming its expectation for the 2023 full year GAAP diluted earnings per share to be flat to low-single digit growth compared to our 2022 reported GAAP diluted earnings per share of $3.34.
The Company continues to expect 2023 revenue to grow at a mid-single digit rate on a local currency basis compared to the Company’s 2022 revenue. The Company continues to expect 2023 diluted earnings per share to be flat to low-single digit growth on a local currency basis compared to the Company’s 2022 adjusted diluted earnings per share(2) of $3.29. The Company continues to expect 2023 adjusted EBITDA(2) to grow at a mid-to-high single digit rate on a local currency basis compared to the Company’s 2022 adjusted EBITDA(2).
The Company expects its 2023 diluted earnings per share to be impacted by higher interest rates and a higher tax rate. Based on current exchange rates, the Company expects foreign exchange rates to be modestly favorable for the full year.
The Company’s guidance is based on current conditions and economic and market trends in the markets in which the Company operates and is subject to various risks and uncertainties as described below. We do not anticipate any divestiture related costs, operational improvement plan costs, or results of divested business in 2023 at this time.
|
(2) See “Reconciliation of Non-GAAP Amounts” at the end of this release for more information. |
USE OF NON-GAAP FINANCIAL MEASURES
The Company’s non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include: currency movements, depreciation and amortization, divestiture and other related costs and income, and non-cash share-based compensation. These measures are provided to enhance the overall understanding of the Company’s performance when viewed together with the GAAP results. Refer to “Reconciliation of Non-GAAP Amounts” at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2023 first quarter financial results at 8:30 a.m. CDT on Friday, April 28, 2023. To participate in the conference call, contact Chorus Call Inc. at (844) 492-3726 or (412) 317-1078, and ask to join the Sensient Technologies Corporation conference call. Alternatively, the call can be accessed by using the webcast link that is available on the Investor Information section of the Company’s web site at www.sensient.com.
A replay of the call will be available one hour after the end of the conference call through May 5, 2023, by calling (877) 344-7529 and referring to conference identification number 5575502. An audio replay and written transcript of the call will also be posted on the Investor Information section of the Company’s web site at www.sensient.com on or after May 2, 2023.
This release contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws including under “2023 Outlook” above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the Company’s ability to manage economic and capital market conditions and the impact of recessions and economic downturns; the impact of macroeconomic and geopolitical volatility, including inflation and shortages impacting the availability and cost of raw materials, energy, and other supplies; the availability and cost of labor, logistics, and transportation; the impact and uncertainty created by the COVID-19 pandemic and efforts to manage it on the global economy, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, governmental regulations and restrictions, and general economic conditions; the uncertain impacts of the ongoing conflict between Russia and Ukraine on our supply chain, input costs, including energy and transportation, and on general economic conditions; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and other factors included in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, and in other documents that the Company files with the SEC. The risks and uncertainties identified above are not the only risks the Company faces. Additional risks and uncertainties not presently known to the Company or that it currently believes to be immaterial also may adversely affect the Company. Should any known or unknown risks and uncertainties develop into actual events, these developments could have material adverse effects on our business, financial condition, and results of operations. This release contains time-sensitive information that reflects management’s best analysis only as of the date of this release. Except to the extent required by applicable laws, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied herein will not be realized.
ABOUT SENSIENT TECHNOLOGIES
Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses advanced technologies and robust global supply chain capabilities to develop specialized solutions for food and beverages, as well as products that serve the pharmaceutical, nutraceutical, and personal care industries. Sensient’s customers range in size from small entrepreneurial businesses to major international manufacturers representing some of the world’s best-known brands. Sensient is headquartered in Milwaukee, Wisconsin.
| Sensient Technologies Corporation | |||||||||||
| (In thousands, except percentages and per share amounts) | |||||||||||
| (Unaudited) | |||||||||||
| Consolidated Statements of Earnings |
Three Months Ended March 31, |
||||||||||
|
|
|
|
|
|
|||||||
|
2023 |
|
2022 |
|
% Change |
|||||||
| Revenue |
$ |
369,006 |
|
$ |
355,521 |
|
3.8 |
% |
|||
| Cost of products sold |
|
244,343 |
|
|
230,675 |
|
5.9 |
% |
|||
| Selling and administrative expenses |
|
73,825 |
|
|
72,057 |
|
2.5 |
% |
|||
| Operating income |
|
50,838 |
|
|
52,789 |
|
(3.7 |
%) |
|||
| Interest expense |
|
6,002 |
|
|
2,993 |
|
|||||
| Earnings before income taxes |
|
44,836 |
|
|
49,796 |
|
|||||
| Income taxes |
|
11,185 |
|
|
12,725 |
|
|||||
| Net earnings |
$ |
33,651 |
|
$ |
37,071 |
|
(9.2 |
%) |
|||
| Earnings per share of common stock: | |||||||||||
| Basic |
$ |
0.80 |
|
$ |
0.89 |
|
|||||
| Diluted |
$ |
0.80 |
|
$ |
0.88 |
|
|||||
| Average common shares outstanding: | |||||||||||
| Basic |
|
41,970 |
|
|
41,865 |
|
|||||
| Diluted |
|
42,255 |
|
|
42,148 |
|
|||||
| Results by Segment |
Three Months Ended March 31, |
||||||||||
|
|
|
|
|
|
|||||||
|
Revenue |
2023 |
|
2022 |
|
% Change |
||||||
| Flavors & Extracts |
$ |
178,852 |
|
$ |
182,727 |
|
(2.1 |
%) |
|||
| Color |
|
161,161 |
|
|
148,438 |
|
8.6 |
% |
|||
| Asia Pacific |
|
40,085 |
|
|
36,465 |
|
9.9 |
% |
|||
| Intersegment elimination |
|
(11,092 |
) |
|
(12,109 |
) |
|||||
| Consolidated |
$ |
369,006 |
|
$ |
355,521 |
|
3.8 |
% |
|||
| Operating Income | |||||||||||
| Flavors & Extracts |
$ |
22,180 |
|
$ |
27,579 |
|
(19.6 |
%) |
|||
| Color |
|
31,885 |
|
|
30,657 |
|
4.0 |
% |
|||
| Asia Pacific |
|
9,241 |
|
|
8,204 |
|
12.6 |
% |
|||
| Corporate & Other |
|
(12,468 |
) |
|
(13,651 |
) |
|||||
| Consolidated |
$ |
50,838 |
|
$ |
52,789 |
|
(3.7 |
%) |
|||
| Sensient Technologies Corporation | ||||||
| (In thousands) | ||||||
| (Unaudited) | ||||||
| Consolidated Condensed Balance Sheets |
March 31, |
|
December 31, |
|||
|
2023 |
|
2022 |
||||
| Cash and cash equivalents |
$ |
24,017 |
$ |
20,921 |
||
| Trade accounts receivable |
|
312,530 |
|
302,109 |
||
| Inventories |
|
573,706 |
|
564,110 |
||
| Prepaid expenses and other current assets |
|
49,639 |
|
47,640 |
||
| Total Current Assets |
|
959,892 |
|
934,780 |
||
| Goodwill & intangible assets (net) |
|
437,871 |
|
434,315 |
||
| Property, plant, and equipment (net) |
|
493,779 |
|
483,193 |
||
| Other assets |
|
131,185 |
|
129,326 |
||
| Total Assets |
$ |
2,022,727 |
$ |
1,981,614 |
||
| Trade accounts payable |
$ |
121,290 |
$ |
142,365 |
||
| Short-term borrowings |
|
24,849 |
|
20,373 |
||
| Other current liabilities |
|
88,512 |
|
109,415 |
||
| Total Current Liabilities |
|
234,651 |
|
272,153 |
||
| Long-term debt |
|
679,779 |
|
630,331 |
||
| Accrued employee and retiree benefits |
|
27,224 |
|
26,364 |
||
| Other liabilities |
|
52,852 |
|
53,168 |
||
| Shareholders’ Equity |
|
1,028,221 |
|
999,598 |
||
| Total Liabilities and Shareholders’ Equity |
$ |
2,022,727 |
$ |
1,981,614 |
||
| Sensient Technologies Corporation | ||||||||
| (In thousands, except per share amounts) | ||||||||
| (Unaudited) | ||||||||
| Consolidated Statements of Cash Flows | ||||||||
| Three Months Ended March 31, | ||||||||
|
2023 |
2022 |
|||||||
| Cash flows from operating activities: | ||||||||
| Net earnings |
$ |
33,651 |
|
$ |
37,071 |
|
||
| Adjustments to arrive at net cash provided by operating activities: | ||||||||
| Depreciation and amortization |
|
14,150 |
|
|
13,056 |
|
||
| Share-based compensation expense |
|
2,267 |
|
|
4,163 |
|
||
| Net loss (gain) on assets |
|
8 |
|
|
(48 |
) |
||
| Deferred income taxes |
|
(2,351 |
) |
|
4,211 |
|
||
| Changes in operating assets and liabilities: | ||||||||
| Trade accounts receivable |
|
(7,142 |
) |
|
(20,841 |
) |
||
| Inventories |
|
(4,374 |
) |
|
(11,901 |
) |
||
| Prepaid expenses and other assets |
|
(2,062 |
) |
|
(11,111 |
) |
||
| Trade accounts payable and other accrued expenses |
|
(19,251 |
) |
|
(10,267 |
) |
||
| Accrued salaries, wages, and withholdings |
|
(21,187 |
) |
|
(12,425 |
) |
||
| Income taxes |
|
2,548 |
|
|
7,063 |
|
||
| Other liabilities |
|
698 |
|
|
137 |
|
||
| Net cash used in operating activities |
|
(3,045 |
) |
|
(892 |
) |
||
| Cash flows from investing activities: | ||||||||
| Acquisition of property, plant, and equipment |
|
(22,278 |
) |
|
(12,736 |
) |
||
| Proceeds from sale of assets |
|
1 |
|
|
89 |
|
||
| Other investing activities |
|
(602 |
) |
|
434 |
|
||
| Net cash used in investing activities |
|
(22,879 |
) |
|
(12,213 |
) |
||
| Cash flows from financing activities: | ||||||||
| Proceeds from additional borrowings |
|
50,827 |
|
|
40,099 |
|
||
| Debt payments |
|
(1,351 |
) |
|
(6,275 |
) |
||
| Dividends paid |
|
(17,255 |
) |
|
(17,211 |
) |
||
| Other financing activities |
|
(7,669 |
) |
|
(1,679 |
) |
||
| Net cash provided by financing activities |
|
24,552 |
|
|
14,934 |
|
||
| Effect of exchange rate changes on cash and cash equivalents |
|
4,468 |
|
|
4,606 |
|
||
| Net increase in cash and cash equivalents |
|
3,096 |
|
|
6,435 |
|
||
| Cash and cash equivalents at beginning of period |
|
20,921 |
|
|
25,740 |
|
||
| Cash and cash equivalents at end of period |
$ |
24,017 |
|
$ |
32,175 |
|
||
| Supplemental Information | ||||||
| Three Months Ended March 31, |
2023 |
2022 |
||||
| Dividends paid per share |
$ |
0.41 |
$ |
0.41 |
||
| Sensient Technologies Corporation | |||||||
| (In thousands, except percentages) | |||||||
| (Unaudited) | |||||||
| Reconciliation of Non-GAAP Amounts | |||||||
| The following table summarizes the percentage change in the 2023 results compared to the 2022 results for the corresponding periods. | |||||||
|
Three Months Ended March 31, |
|||||||
| Revenue |
Total |
|
Foreign Exchange Rates |
|
Local Currency |
||
| Flavors & Extracts |
(2.1%) |
|
(0.8%) |
|
(1.3%) |
||
| Color |
8.6% |
|
(1.4%) |
|
10.0% |
||
| Asia Pacific |
9.9% |
|
(4.7%) |
|
14.6% |
||
| Total Revenue |
3.8% |
|
(1.4%) |
|
5.2% |
||
|
|
|
|
|
|
|||
| Operating Income |
|
|
|
|
|
||
| Flavors & Extracts |
(19.6%) |
|
(0.1%) |
|
(19.5%) |
||
| Color |
4.0% |
|
(2.3%) |
|
6.3% |
||
| Asia Pacific |
12.6% |
|
(5.4%) |
|
18.0% |
||
| Corporate & Other |
(8.7%) |
|
(0.1%) |
|
(8.6%) |
||
| Total Operating Income |
(3.7%) |
|
(2.2%) |
|
(1.5%) |
||
| Diluted Earnings Per Share |
(9.1%) |
|
(2.3%) |
|
(6.8%) |
||
| Adjusted EBITDA |
(3.9%) |
|
(1.9%) |
|
(2.0%) |
||
| The following table summarizes the reconciliations between Operating Income (GAAP) and Adjusted EBITDA for the three months ended March 31, 2023 and 2022. | |||||||||
|
Three Months Ended March 31, |
|||||||||
|
2023 |
|
2022 |
|
% Change |
|||||
| Operating income (GAAP) |
$ |
50,838 |
$ |
52,789 |
(3.7%) |
||||
| Depreciation and amortization |
|
14,150 |
|
13,056 |
|
||||
| Share-based compensation expense |
|
2,267 |
|
4,163 |
|
||||
| Adjusted EBITDA |
$ |
67,255 |
$ |
70,008 |
(3.9%) |
||||
| The following table summarizes the reconciliation between Debt (GAAP) and Net Debt, and Operating Income (GAAP) and Credit Adjusted EBITDA for the trailing twelve months ended March 31, 2023 and 2022. | ||||||||||
|
March 31, |
||||||||||
| Debt |
2023 |
|
2022 |
|||||||
| Short-term borrowings |
$ |
24,849 |
|
$ |
7,475 |
|
||||
| Long-term debt |
|
679,779 |
|
|
530,005 |
|
||||
| Credit Agreement adjustments(1) |
|
(11,525 |
) |
|
(18,590 |
) |
||||
| Net Debt |
$ |
693,103 |
|
$ |
518,890 |
|
||||
| Operating income (GAAP) |
$ |
194,800 |
|
$ |
175,920 |
|
||||
| Depreciation and amortization |
|
53,561 |
|
|
52,308 |
|
||||
| Share-based compensation expense |
|
14,242 |
|
|
11,623 |
|
||||
| Other non-operating (gains) losses(2) |
|
(3,359 |
) |
|
8,544 |
|
||||
| Credit Adjusted EBITDA |
$ |
259,244 |
|
$ |
248,395 |
|
||||
| Net Debt to Credit Adjusted EBITDA |
2.7x |
2.1x |
||||||||
| (1) Adjustments include cash and cash equivalents, as described in the Company’s Third Amended and Restated Credit Agreement (Credit Agreement), and certain letters of credit and hedge contracts. | ||||||||||
| (2) Adjustments consist of certain financing transaction costs, certain non-financing interest items, and gains and losses related to certain non-cash, non-operating, and/or non-recurring items as described in the Credit Agreement. | ||||||||||
| The following table summarizes the reconciliation between Diluted Earnings Per Share (GAAP) and Adjusted Diluted Earnings Per Share for the twelve months ended December 31, 2022. | ||||||
| Twelve Months Ended December 31, | ||||||
|
2022 |
||||||
| Diluted earnings per share (GAAP) |
$ |
3.34 |
|
|||
| Divestiture & other related income, net of tax |
|
(0.04 |
) |
|||
| Adjusted diluted earnings per share |
$ |
3.29 |
|
|||
| Note: Earnings per share calculations may not foot due to rounding differences. | ||||||
| We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this release and our SEC filings. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends, and we believe the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies. With respect to Net Debt to Credit Adjusted EBITDA, this represents our leverage ratio as calculated for purposes of compliance with covenants under our Credit Agreement. In addition to use for these purposes, management utilizes this measure to assess leverage trends and may from time to time disclose it to investors to be used for these purposes. | ||||||
Category: Earnings
Contacts
Amy Agallar
(414) 347-3706